Login / Signup

A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition.

Kit Yee CheahKar Yee MahLai Hui PangShi Min NgJia Woei WongSiew Siew TanHong Zhe TanKah Hay Yuen
Published in: BMC pharmacology & toxicology (2020)
NMRR- 17-1266-36,001; registered and approved on 12 September 2017.
Keyphrases
  • clinical trial